Physician profile
Beevash Ray
NPI 1720313745
$1,638.81
in general payments reported to CMS, 2019-2025
13 companies · $707 in 2025
The $707 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.83 · 2020: $50.78 · 2021: $136 · 2022: $264 · 2023: $382 · 2024: $54.75 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $676 · Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $675.88 |
| Food and Beverage | $468.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $884.42 | 2019-2025 | Triclip, Amplatzer Amulet, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.06 | 2022-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $127.05 | 2021-2023 | Xarelto |
| Pfizer INC. | $120.91 | 2022-2023 | |
| Medtronic, INC. | $89.45 | 2022-2023 | Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $67.11 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $45.94 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $36.17 | 2024 | Optimizer |
| Amgen INC. | $33.55 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.43 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $31.43 | 2020-2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Lantheus Medical Imaging, INC. | $21.28 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beevash Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.